Microvessel density in brain tumors

Anticancer Research

Volumn 17, Issue 6 D, 1997, Pages 4747-4753

  Assimakopoulou, Martha ^a   Sotiropoulou Bonikou, Georgia ^a   Maraziotis, Theodoros ^a   Papadakis, Nikolaos ^a   Varakis, Ioannis ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Angiogenesis; Brain tumors; Factor VIII related antigen immunohistochemistry

Indexed keywords

ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER GRADING; EPENDYMOMA; GLIOBLASTOMA; GLIOSARCOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MEDULLOBLASTOMA; MENINGIOMA; MICROVASCULATURE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ASTROCYTOMA; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; OLIGODENDROGLIOMA; SEX FACTORS;

EID: 0031427222     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Assimakopoulou M, Sotiropoulou-Bonikou G, Maraziotis T, Varakis I: Does sex steroid receptor status have any prognostic or predictive significance in brain astrocytic tumors? Clinical Neuropathology 1997, submitted.
2. Assimakopoulou M, Sotiropoulou-Bonikou G, Maraziotis T, Varakis I: Prognostic significance of Hsp27 in astrocytic brain tumors: an immunohistochemical study. Anticancer Res 17 (4): 2677-2682, 1997.
3. Assimakopoulou M: Immunohistochemical detection of sex steroid receptors, Hsp27, PS2 and angiogenesis in neoplasms of Central Nervous System. Thesis, 1996.
4. Baillie CT, Winslet MC, Bradley NJ: Tumour vasculature -a potential therapeutic target. Br J Cancer 72: 257-267, 1995.
5. Bohling T, Hatva E, Kujala M, Claesson-Welsh L, Alitato K, Haltia M: Expression of growth factors and growth factor receptors in capillary hemangioblastoma. J Neuropathol Exp Neurol 55(5): 522-527, 1996.
6. Bosari S, Lee AKC, De Lellis RA, Wiley BD, Heatley GJ, Silverman ML: Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 23: 755-761, 1992.
7. Brem S, Tsanaclis AM, Gately S, Gross JL, Herblin WF: Immunolocalization of basic fibroblast growth factor to the microvasculature of human brain tumors. Cancer 70(11): 2673-2680, 1992.
8. Burger PC, Vogel S, Green SB, Strike TA: Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 56: 1106-1111, 1985.
9. Chodak GW, Hospelhorn V, Judge SM, Mayforth R, Koeppen H, Sasse J: Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer. Cancer Res 48: 2083-2088, 1988.
10. Coons SW, Johnson PC, Scheithauer BW, Yates AJ, Pearl DK: Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 79(7): 1381-1393, 1997.
11. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P: Grading of astrocytomas. A simple and reproducible method. Cancer 62: 2152-2165, 1988.
12. Folkman J, Klagsbrun M: Angiogenic factors. Science 235: 442-447, 1987.
13. Folkman J, Watson K, Ingber D, Hanahan D: Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58-61, 1989.
14. Folkman JD: Clinical application of research on angiogenesis. N Engl J Med 333(26): 1757-1763, 1995.
15. Fox SB, Gatter KC, Bicknell R, Going JJ, Stanton P, Cooke TG et al: Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res 53: 4161-4163, 1993.
16. Fujimoto K, Ichimori Y, Kakizoe T, Okajima E, Sakamoto H, Sugimura T. et al: Increase serum levels of basic fibroblast growth factor in patients with renal carcinoma. Biochem Biophys Res Commun 180: 386-392, 1991.
17. Furcht LT: Critical factors controlling angiogenesis: cell products, cell matrix and growth factors. Lab Invest 55(5): 505-509, 1986.
18. Gasparini G, Toi M, Cion M, Verderio P, Dittadi R, Hanatani M, Matsubara I, Vinante O, Bonoldi E, Borrachi P, Gatti C, Suzuki H, Tominaga T: Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J Natl Cancer Inst 89(2): 139-47, 1997.
19. Goldman CK, Kim J, Wong WL, King V, Brock T, Gillespie GY: Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol Biol Cell 4(1): 121-133, 1993.
20. Guidi AJ, Abu-Jawbeh G, Berse B, Jackman RW, Tognazzi K, Dvozak HF, Brown LF: Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesiS in cervical neoplasia. J Natl Cancer Inst 87: 1237-1245, 1995.
21. Haddad SF, Moore SA, Schelper RL, Goeken JA: Vascular smooth muscle hyperplasia underlies the formation of glomeruloid vascular structures of glioblastoma multiforme. J Neuropathol Exp Neurol 51: 488-492, 1992.
22. Hatva E, Kaipainen A, Mentula P, Jaaskelainen J, Paetau A, Haltia M, Alitalo K: Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Pathol 146(2): 368-378, 1995.
23. Hayosteck CJ, Shaw EG, Scheithauer B, O'Fallon JR, Weiland TL, Schomberg PJ et al: Astrocytomas of the cerebellum: a comparative clinicopathologic study of pilocytic and diffuse astrocytomas. Cancer 72: 856-869, 1993.
24. Heimann R, Ferguson D, Powers C, Recant WM, Weichselbaum RR, Hellman S: Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. J Natl cancer Inst 88(23): 1764-1769, 1996.
25. Hobson B, Denekamp J: Endothelial proliferation in tumors and normal tissues: continuous labelling studies. Br J Cancer 49: 405-413, 1984.
26. Kleihues P, Burger PC, Scheithauer BW: Histological typing of tumours of the central nervous system. 2nd Edition.Berlin: Springer-Verlag, 11-30, 1993.
27. Leon SP, Folkerth RD, Black P: Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 77: 362-372, 1996.
28. Li VW, Folkerth RD, Watanabe H, Channing Y, Rupnick M, Barnes P et al: Basic fibroblast growth factor in cerebrospinal fluid of children with brain tumors-correlation with microvessel count in the tumor. Lancet 344: 82-86, 1994.
29. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA: Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet 340: 145-146, 1992.
30. Maxwell M, Naber SP, Wolfe HJ, Hedley-Whyte ET, Galanopoulos T, Neville-Golden J, Antoniades HN: Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression. Cancer Res 51(4): 1345-1351, 1991.
31. 1. Br J Cancer 70: 199-203, 1994.
32. Morrison RS, Gross JL, Herblin WF, Reilly TM, et al: Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell line. Cancer Res 50: 2524-29, 1990.
33. Nemati MN, Stan AC, Putz KM, Pietsch T, Walter GF, Dietz H: [Inhibition of angiogenesis and growth of malignant gliomas in the athymic nude rat model: immunotherapy against "basic fibroblast growth factor"]. Zentralbl Neurochir 57(1): 12-9, 1996.
34. Plate KH, Breier G, Welch HA, Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359: 845-848, 1992.
35. th ed. Baltimore: Williams and Wilkins, 1989: 83-350.
36. Saleh M. Stacker SA, Wilks AF: Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res 56(2): 393-401, 1996.
37. Samoto K, Ikezaki K, Ono M, Shono T, Koho K, Kuwano M, Fukui M: Expression of vascular endothelial growth factor and its possible relation with neovascularization in human braintumors. Cancer Res 55(5): 1189-1193, 1995.
38. Stan AC, Nemati MN, Pietsch T, Walter GF, Dietz H: In vivo inhibition of angiogenesis and growth of the human U-87 malignant glial tumor by treatment with an antibody against basic fibroblast growth factor. J Neurosurg 82(6): 1044-52, 1995.
39. Watanabe H, Nguyen M, Schizer M, Li V, Hayes DF, Shizer M, E:i V, Hayes DF, Sallan S, et al: Basic fibroblast growth factor in human serum: a prognostic test for breast cancer. Mol Biol Cell (Suppl): 234a, 1359A, 1992.
40. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143: 401-409, 1993.
41. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, et al: Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84: 1875-1887, 1992.
42. Weidner N, Semple J, Welch WR, Folkman J: Tumor angiogenesis-correlation in invasive breast catcinoma. N Engl J Med 324(1): 1-8, 1991.
43. Weindel K, Moringlane JR, Marme D, Weich HA: Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis? Neurosurgery 35(3): 439-448, 1994.
44. Yazaki T, Takamiya Y, Costello PC, Mineta T, Menon AG, Radkin SD, Martuza RL: Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470. J Neurooncol 23(1): 23-29, 1995.
45. Zagzag D, Miller DC, Sato Y, Rifkin DB, Burstein DE: Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Cancer Res 50(22): 7393-7398, 1990.